We are live on
!
Find out more
SC
SMA Capital Portfolio holdings
AUM
$238M
This Fund
S&P 500
This Quarter
Est. Return
+14.62%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
+$6.45M
(+2.8%)
Cap. Flow
-$11.8M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
37.07%
Holding
184
New
89
Increased
22
Reduced
10
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$7.92M |
| 2 |
ITT
ITT
|
+$7.28M |
| 3 |
Packaging Corp of America
PKG
|
+$7.02M |
| 4 |
JB Hunt Transport Services
JBHT
|
+$6.42M |
| 5 |
Teledyne Technologies
TDY
|
+$6.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$10.3M |
| 2 |
Eaton
ETN
|
+$10.1M |
| 3 |
Caterpillar
CAT
|
+$9.48M |
| 4 |
Ferguson
FERG
|
+$8.32M |
| 5 |
Linde
LIN
|
+$7.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 55.56% |
| 2 | Consumer Discretionary | 17.53% |
| 3 | Technology | 8.66% |
| 4 | Materials | 6.15% |
| 5 | Consumer Staples | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
126
Boeing
BA
$167B
| – | – |
-51,716
| Closed | -$10.3M |
|
127
Biogen
BIIB
$32.6B
| – | – |
-120
| Closed | -$22K |
|
128
Bristol-Myers Squibb
BMY
$138B
| – | – |
-359
| Closed | -$21.8K |
|
129
Bruker
BRKR
$8.67B
| – | – |
-155
| Closed | -$5.6K |
|
|
130
Caterpillar
CAT
$377B
| – | – |
-13,375
| Closed | -$9.48M |
|
131
Celcuity
CELC
$4.63B
| – | – |
-54
| Closed | -$6.16K |
|
132
Cigna
CI
$74.9B
| – | – |
-77
| Closed | -$20.5K |
|
133
Corcept Therapeutics
CORT
$13.3B
| – | – |
-172
| Closed | -$6.93K |
|
134
Canadian Pacific Kansas City
CP
$83.5B
| – | – |
-45,000
| Closed | -$3.54M |
|
|
CPRX
135
DELISTED
Catalyst Pharmaceutical
CPRX
| – | – |
-262
| Closed | -$6.49K |
|
136
Charles River Laboratories
CRL
$14.2B
| – | – |
-34
| Closed | -$5.87K |
|
137
Carpenter Technology
CRS
$24B
| – | – |
-15,947
| Closed | -$6.29M |
|
138
Casella Waste Systems
CWST
$5.93B
| – | – |
-35,000
| Closed | -$2.78M |
|
139
Doximity
DOCS
$4.46B
| – | – |
-895
| Closed | -$20.9K |
|
140
Dover
DOV
$27.6B
| – | – |
-35,871
| Closed | -$7.48M |
|
141
Elanco Animal Health
ELAN
$12.5B
| – | – |
-872
| Closed | -$20.9K |
|
142
Emerson Electric
EMR
$87.6B
| – | – |
-35,000
| Closed | -$4.59M |
|
|
143
Eaton
ETN
$162B
| – | – |
-28,200
| Closed | -$10.1M |
|
144
Edwards Lifesciences
EW
$52.4B
| – | – |
-260
| Closed | -$20.8K |
|
|
145
Ferguson
FERG
$45.6B
| – | – |
-35,662
| Closed | -$8.32M |
|
|
FOLD
146
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-421
| Closed | -$6.09K |
|
147
GXO Logistics
GXO
$5.55B
| – | – |
-76,249
| Closed | -$3.95M |
|
148
Halozyme
HALO
$12.3B
| – | – |
-87
| Closed | -$5.62K |
|
149
Home Depot
HD
$336B
| – | – |
-13,000
| Closed | -$4.28M |
|
150
HealthEquity
HQY
$8.71B
| – | – |
-295
| Closed | -$24.7K |
|
Similar funds
RMC
PFA
TCM
SAM
CWM
GRWP
CNBOF
NSB
SMA Capital's Q2 2026 Portfolio in Review
As of Q2 2026, SMA Capital held 184 positions worth $238M, up 2.8% from $232M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
SMA Capital withdrew a net $11.8M in Q2 2026, closing 63 positions and reducing 10 holdings. Its most notable exit was Boeing, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 56% of assets, down from 79% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, SMA Capital opened a new position in CRH worth $7.7M.
- SMA Capital's largest Q2 2026 buy was CRH: 72,000 shares worth $7.7M.
- SMA Capital added most to Ametek in Q2 2026, an estimated $2.33M increase.
- SMA Capital's biggest Q2 2026 reduction was Applied Industrial Technologies, cutting an estimated $5.83M.
- SMA Capital fully exited Boeing in Q2 2026, selling an estimated $10.3M.
- SMA Capital's ten largest holdings make up 37% of its $238M portfolio in Q2 2026.
- SMA Capital opened 89 new positions and closed 63 in Q2 2026.
- SMA Capital's portfolio value rose 2.8% quarter-over-quarter to $238M.
Based on SMA Capital's 13F filing for Q2 2026, filed 14 Aug 2026.